Tecan Group AG
Research Tecan Group AG (TECN) on Bullrun: market cap CHF 2.36B, dividend yield 1.5%. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerTECN
- ExchangeSW
- CountrySwitzerland
- SectorHealthcare
- IndustryMedical Instruments & Supplies
- CurrencyCHF
- Market capCHF 2.36B
- Dividend yield1.5%
- Financial periodFY2025
- RevenueCHF 882.48M
- Revenue growth-5.5%
- Net income-CHF 110.65M
- Free cash flowCHF 102.67M
- Gross margin35.2%
Valuation Snapshot
latest market cap is CHF 2.36B; dividend yield is 1.5%.
Peer valuation comparison
Latest dividend yield is 1.54% versus a Healthcare sector median of 2.11% (27.0% below).
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | CHF 882.48M | -CHF 110.65M | CHF 102.67M | 35.2% | -8.74 | CHF 176.37M | CHF 218.33M | CHF 1.15B |
| FY2024 | CHF 934.28M | CHF 67.66M | CHF 117.86M | 34.3% | n/a | CHF 154.19M | CHF 321.35M | CHF 1.44B |
| FY2023 | CHF 1.07B | CHF 132.08M | CHF 125.63M | 36.3% | 10.3 | CHF 132.97M | CHF 316.09M | CHF 1.35B |
| FY2022 | CHF 1.14B | CHF 121.13M | CHF 92.04M | 38.3% | 9.47 | CHF 111.44M | CHF 307.68M | CHF 1.36B |
| FY2021 | n/a | n/a | n/a | n/a | 9.88 | n/a | n/a | n/a |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-08-24 | CHF 2.36B | n/a | 1.6% | 3 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 3 CHF, yield 1.5%.
| Year | Dividends/share |
|---|---|
| FY2025 | 3 CHF |
| FY2024 | 3 CHF |
| FY2023 | 2.9 CHF |
| FY2022 | 2.8 CHF |
| FY2021 | 2.3 CHF |
About Tecan Group AG
Tecan Group AG provides laboratory instruments and solutions in biopharmaceuticals, forensics, and clinical diagnostics in Europe, North America, Asia, and internationally. It operates in two segments: Life Sciences Business and Partnering Business. The company offers liquid handling and automation, microplate readers and washers, software, consumables, sequencing reagents, immunoassays and antibodies, and Tecan Labwerx, an end-to-end automation solution.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Tecan Group AG's market cap?
Tecan Group AG's market capitalization is CHF 2.36B.
Does Tecan Group AG pay a dividend?
Tecan Group AG has a dividend yield of 1.5%.
What does Tecan Group AG do?
Tecan Group AG provides laboratory instruments and solutions in biopharmaceuticals, forensics, and clinical diagnostics in Europe, North America, Asia, and internationally. It operates in two segments: Life Sciences Business and Partnering Business. The company offers liquid handling and automation, microplate readers and washers, software, consumables, sequencing reagents, immunoassays and antibodies, and Tecan Labwerx, an end-to-end automation solution. It also provides PARAMIT, a contract design and manufacturing service.